Entera Bio

Entera Bio Days Inventory Outstanding

The Days Inventory Outstanding (DIO) of Entera Bio (ENTX) as of Oct 31, 2026 is -1,062.48. In the previous year, Days Inventory Outstanding (DIO) was -162.42 — a change of 554.17% (lower).

Days Inventory Outstanding

-1,062.48

YoY

554.17%

Last updated:

Days Inventory Outstanding (DIO) of Entera Bio is 2022 -1,062.48 . Days Inventory Outstanding (DIO) of Entera Bio was 2021 -162.42 . It decreases by 554.17% lower compared to the previous year.

The Entera Bio Days Inventory Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Days Inventory Outstanding
Date
Days Inventory Outstanding
Jan 1, 2019
61.92 USD
Jan 1, 2020
-162.42 USD
Jan 1, 2022
-1,062.48 USD
The Entera Bio Days Inventory Outstanding history
YEARDays Inventory OutstandingYoY
-1,062.48+554.17%
-162.42-362.30%
61.92—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Entera Bio Stock analysis

What does Entera Bio do? Entera Bio Ltd is an emerging biotechnology company focused on developing oral medications to treat unmet medical needs. The company was founded in 2010 and is headquartered in Jerusalem, Israel. Its history began with the discovery of the "EnteraGam" molecule in the intestinal cells of breastfed infants, which helps them fight infections. This led to the development of EnteraGam for the treatment of various autoimmune diseases. The company's business model is based on developing oral formulations for existing drugs and discovering and developing new molecules. Its focus areas are osteoporosis, hypoparathyroidism, chronic kidney disease, and autoimmune diseases. Entera Bio is divided into three business divisions: the Oral Protein Delivery Platform, the Oral Parathyroid Hormone (PTH) Platform, and the Collagen-based Platform for Wound Healing. Its products include EB611, a candidate for hypoparathyroidism treatment, EB613 for osteoporosis treatment, and EB612 for chronic kidney disease. These products have potential to improve the lives of millions of patients worldwide. Entera Bio is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Entera Bio stock

Days Inventory Outstanding (DIO) of Entera Bio is -1,062.48 in 2022.

Days Inventory Outstanding (DIO) of Entera Bio changed from -162.42 to -1,062.48, representing a 554.17% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Days Inventory Outstanding (DIO) Entera Bio since 2006 – with annual values, charts, and detailed analysis.

DIO measures the average number of days inventory is held before being sold. Lower values indicate more efficient inventory management.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Days Inventory Outstanding (DIO)'s Entera Bio with sector peers and the industry average to assess whether it is attractive.

To evaluate Days Inventory Outstanding (DIO)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Days Inventory Outstanding (DIO).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Entera Bio

All Key Metrics — Entera Bio